International collaboration plays an essential role in accelerating healthcare innovation, creating opportunities for knowledge exchange, market access, and the development of solutions that address global health challenges. Initiatives that connect innovation ecosystems across countries can help emerging technologies reach new audiences and unlock valuable partnerships.
On 21 September 2026, Fetalix participated in the HealthTech Innovation Access Day Portugal/Brazil, hosted by i3S. The event was dedicated to strengthening connections between Portuguese health technologies and the Brazilian healthcare ecosystem, bringing together innovators, researchers, industry stakeholders, and experts from both countries.
Throughout the event, participants gained valuable insights into the structure of the Brazilian healthcare system, its regulatory landscape, and the opportunities available for innovative health technologies seeking international expansion. The discussions highlighted the importance of cross-border collaboration in facilitating the adoption of new healthcare solutions and fostering innovation-driven partnerships.
Representing Fetalix, the CEO Joana Caldeira pitched the company's regenerative medicine approach for the treatment of chronic low back pain. The presentation generated significant interest among attendees, reflecting the broad relevance of musculoskeletal health challenges and the growing demand for innovative therapies capable of addressing unmet clinical needs.Beyond the presentations, the event provided an important platform for networking and exchanging experiences with key stakeholders from the healthcare and innovation sectors. Participants had the opportunity to explore potential avenues for collaboration while discovering a range of innovative projects being developed across the Portuguese research and entrepreneurial landscape.
By participating in HealthTech Innovation Access Day Portugal/Brazil, Fetalix contributed to the ongoing dialogue between the Portuguese and Brazilian healthcare ecosystems, reinforcing the value of international cooperation in advancing medical innovation and accelerating the development of technologies with the potential to improve patient outcomes.
Fetalix would like to thank the i3S Knowledge Transfer Unit and all organisers for creating a valuable initiative that fostered meaningful connections, facilitated knowledge exchange, and showcased the strength of innovation emerging from the health sector.
September 21, 2026
